Logo image of U6Z.DE

URANIUM ENERGY CORP (U6Z.DE) Stock Fundamental Analysis

Europe - FRA:U6Z - US9168961038 - Common Stock

11.318 EUR
-0.03 (-0.25%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, U6Z scores 3 out of 10 in our fundamental rating. U6Z was compared to 62 industry peers in the Oil, Gas & Consumable Fuels industry. U6Z has a great financial health rating, but its profitability evaluates not so good. U6Z does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

U6Z had negative earnings in the past year.
U6Z had a negative operating cash flow in the past year.
In the past 5 years U6Z reported 4 times negative net income.
U6Z had negative operating cash flow in 4 of the past 5 years.
U6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFU6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

U6Z's Return On Assets of -7.51% is on the low side compared to the rest of the industry. U6Z is outperformed by 87.10% of its industry peers.
U6Z has a Return On Equity of -8.48%. This is amonst the worse of the industry: U6Z underperforms 85.48% of its industry peers.
Industry RankSector Rank
ROA -7.51%
ROE -8.48%
ROIC N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
U6Z.DE Yearly ROA, ROE, ROICU6Z.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Gross Margin value of 36.62%, U6Z perfoms like the industry average, outperforming 41.94% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for U6Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
U6Z.DE Yearly Profit, Operating, Gross MarginsU6Z.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

8

2. Health

2.1 Basic Checks

U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, U6Z has more shares outstanding
Compared to 5 years ago, U6Z has more shares outstanding
U6Z has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
U6Z.DE Yearly Shares OutstandingU6Z.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
U6Z.DE Yearly Total Debt VS Total AssetsU6Z.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 31.70 indicates that U6Z is not in any danger for bankruptcy at the moment.
U6Z has a better Altman-Z score (31.70) than 98.39% of its industry peers.
U6Z has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31.7
ROIC/WACCN/A
WACC8.77%
U6Z.DE Yearly LT Debt VS Equity VS FCFU6Z.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 10.11 indicates that U6Z has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 10.11, U6Z belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
U6Z has a Quick Ratio of 5.05. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of U6Z (5.05) is better than 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 10.11
Quick Ratio 5.05
U6Z.DE Yearly Current Assets VS Current LiabilitesU6Z.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for U6Z have decreased strongly by -300.00% in the last year.
Looking at the last year, U6Z shows a very negative growth in Revenue. The Revenue has decreased by -99.86% in the last year.
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-99.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 57.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, U6Z will show a very strong growth in Revenue. The Revenue will grow by 59.34% on average per year.
EPS Next Y-354.5%
EPS Next 2Y29.78%
EPS Next 3Y80.84%
EPS Next 5Y57.53%
Revenue Next Year94.09%
Revenue Next 2Y26.27%
Revenue Next 3Y53.67%
Revenue Next 5Y59.34%

3.3 Evolution

U6Z.DE Yearly Revenue VS EstimatesU6Z.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
U6Z.DE Yearly EPS VS EstimatesU6Z.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 -0.1 0.2 -0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for U6Z. In the last year negative earnings were reported.
Also next year U6Z is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
U6Z.DE Price Earnings VS Forward Price EarningsU6Z.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U6Z.DE Per share dataU6Z.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as U6Z's earnings are expected to grow with 80.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.78%
EPS Next 3Y80.84%

0

5. Dividend

5.1 Amount

No dividends for U6Z!.
Industry RankSector Rank
Dividend Yield N/A

URANIUM ENERGY CORP

FRA:U6Z (10/3/2025, 7:00:00 PM)

11.318

-0.03 (-0.25%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)09-24 2025-09-24/bmo
Earnings (Next)12-02 2025-12-02
Inst Owners89.84%
Inst Owner ChangeN/A
Ins Owners1.68%
Ins Owner ChangeN/A
Market Cap5.26B
Analysts78.46
Price Target12.77 (12.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)34.45%
PT rev (3m)46.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-566.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-227.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-43.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 92.34
P/FCF N/A
P/OCF N/A
P/B 6.91
P/tB 33.83
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.12
BVpS1.64
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.51%
ROE -8.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.62%
FCFM N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 247.26%
Cap/Sales 8.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.11
Quick Ratio 5.05
Altman-Z 31.7
F-Score3
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)135.76%
Cap/Depr(5y)103.6%
Cap/Sales(3y)511.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y-354.5%
EPS Next 2Y29.78%
EPS Next 3Y80.84%
EPS Next 5Y57.53%
Revenue 1Y (TTM)-99.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year94.09%
Revenue Next 2Y26.27%
Revenue Next 3Y53.67%
Revenue Next 5Y59.34%
EBIT growth 1Y-78.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-282.21%
EBIT Next 3Y42.94%
EBIT Next 5Y60.09%
FCF growth 1Y-316.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-292.66%
OCF growth 3YN/A
OCF growth 5YN/A